Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
The paper analyzes the use of movalis (meloxicam) in 150 patients with nonspecific back pain in the outpatient setting. Movalis was given in a single daily oral dose of 15 mg throughout the follow-up; the oral use of the drug was, if required, preceded by a 3-day course of its intramuscular administ...
Saved in:
| Main Authors: | O. N. Gerasimova, V. A. Parfenov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2011-12-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/102 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The issues of safety and pharmacoeconomics in the management of chronic pain in the back and limbs
by: Vladimir Anatol'evich Parfenov, et al.
Published: (2011-06-01) -
Management of patients with back pain in outpatient practice
by: O. N. Gerasimova, et al.
Published: (2010-12-01) -
Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01) -
The Study of the Effectiveness of Meloxicam “Movalis” Application in Postoperative Patients with Planovalgus Foot Deformity
by: Yatskevych A., et al.
Published: (2016-12-01) -
General medical aspects of the use of meloxicam (Movalis®) in clinical practice: Efficacy and safety
by: Natalia Vladimirovna Chichasova
Published: (2012-12-01)